QbD optimized abiraterone acetate-loaded nanostructured lipid carriers enhanced intracellular uptake and modulated cell cycle distribution in prostate cancer cells

Prostate cancer is a leading cause of cancer death in men, with advanced disease exhibiting poor treatment response and low long-term survival. Abiraterone acetate (AbiA) is a progesterone derivative used to treat metastatic prostate cancer, exhibits poor aqueous solubility and low bioavailability, which may result in subtherapeutic drug exposure at the tumor site, and reduced therapeutic efficacy. The present study aims to develop AbiA-loaded nanostructured lipid carriers using the “Quality by Design” strategy in JMP ® Pro. A Plackett-Burman Design was employed for screening significant variables, followed by a Central Composite Design for formulation optimization. The optimized AbiA-NLCs had a particle size of 143.43 ± 2.10 nm, a polydispersity index of 0.164 ± 0.01, a zeta potential of -10.83 ± 0.20 mV, and an entrapment efficiency of 88.76 ± 1.10%. The SEM analysis demonstrated that particles are uniform and spherical. In vitro drug release of AbiA-NLCs in pH 7.4 phosphate-buffered saline with 1% β-cyclodextrin showed improved and sustained drug release compared to AbiA. The optimized AbiA-NLCs showed a nearly two-fold increase in anticancer activity against PC-3 cells, compared to AbiA. Cellular uptake, apoptosis, cell cycle, and colony-forming assays consistently demonstrated the improved anticancer potential of the developed AbiA-NLCs.

Authors

Institutions

Publication Details

Journal
Discover Nano
Published
2026-11-17
DOI
https://doi.org/10.1186/s11671-026-05084-6
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

QbD optimized abiraterone acetate-loaded nanostructured lipid carriers enhanced intracellular uptake and modulated cell cycle distribution in prostate cancer cells

Aakanchha Jain, Vasu Peddinti
4 links
Discover Nano
Nanoparticle-Based Drug Delivery
article

QbD optimized abiraterone acetate-loaded nanostructured lipid carriers enhanced intracellular uptake and modulated cell cycle distribution in prostate cancer cells

Aakanchha Jain, Vasu Peddinti
article en

Abstract

Prostate cancer is a leading cause of cancer death in men, with advanced disease exhibiting poor treatment response and low long-term survival. Abiraterone acetate (AbiA) is a progesterone derivative used to treat metastatic prostate cancer, exhibits poor aqueous solubility and low bioavailability, which may result in subtherapeutic drug exposure at the tumor site, and reduced therapeutic efficacy. The present study aims to develop AbiA-loaded nanostructured lipid carriers using the “Quality by Design” strategy in JMP ® Pro. A Plackett-Burman Design was employed for screening significant variables, followed by a Central Composite Design for formulation optimization. The optimized AbiA-NLCs had a particle size of 143.43 ± 2.10 nm, a polydispersity index of 0.164 ± 0.01, a zeta potential of -10.83 ± 0.20 mV, and an entrapment efficiency of 88.76 ± 1.10%. The SEM analysis demonstrated that particles are uniform and spherical. In vitro drug release of AbiA-NLCs in pH 7.4 phosphate-buffered saline with 1% β-cyclodextrin showed improved and sustained drug release compared to AbiA. The optimized AbiA-NLCs showed a nearly two-fold increase in anticancer activity against PC-3 cells, compared to AbiA. Cellular uptake, apoptosis, cell cycle, and colony-forming assays consistently demonstrated the improved anticancer potential of the developed AbiA-NLCs.

Discover NanoVol. 21(1)
National Institute of Pharmaceutical Education and Research - Ahmedabad (IN)
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon